Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen.
Charpentier C, Roquebert B, Colin C, Taburet AM, Fagard C, Katlama C, Molina JM, Jacomet C, Brun-Vézinet F, Chêne G, Yazdanpanah Y, Descamps D; ANRS 139 TRIO Trial study group.
Charpentier C, et al. Among authors: taburet am.
AIDS. 2010 Nov 13;24(17):2651-6. doi: 10.1097/QAD.0b013e32833ed2a7.
AIDS. 2010.
PMID: 20802293
Clinical Trial.